- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer.
September 16, 2020
Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients.
September 16, 2020
Patient factors predict complications after partial nephrectomy: Validation and calibration of the PREP (Preoperative Risk Evaluation for Partial Nephrectomy) score.
September 16, 2020
Clear cell renal cell carcinoma with osseous metaplasia: Two extremely rare cases and review of the literature.
September 15, 2020
Pathological features and outcomes of incidental renal cell carcinoma in candidate solid organ donors.
September 15, 2020
Gender difference analysis of Xp11.2 translocation renal cell carcinomas's attack rate: a meta-analysis and systematic review.
September 15, 2020
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-Line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma.
September 14, 2020
Perioperative and Long-Term Outcomes of Robot-Assisted Partial Nephrectomy: A Systematic Review.
September 14, 2020
Outcomes in Patients with Renal Cell Carcinoma Undergoing Inferior Vena Cava Ligation without Reconstruction versus Thrombectomy: A Retrospective, Case-Controlled Study.
September 11, 2020
Radiation induces dynamic changes to the T cell repertoire in renal cell carcinoma patients.
September 11, 2020
Actin-binding protein Profilin1 promotes aggressiveness of clear cell renal cell carcinoma cells.
September 11, 2020
Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer.
September 11, 2020
Safety and Oncologic Outcomes of Magnetic Resonance Imaging-Guided Cryoablation of Renal Cell Carcinoma: A 10-Year Single-Center Experience.
September 10, 2020
Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma.
September 10, 2020
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial.
September 10, 2020
Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy.
September 9, 2020